Advanced Glycation End Products-Induced Activation of Keratinocytes: A Mechanism Underlying Cutaneous Immune Response in Psoriasis

Advanced Glycation End Products-Induced Activation of Keratinocytes: A Mechanism Underlying Cutaneous Immune Response in Psoriasis

Psoriasis is a common inflammatory skin disease, in which epidermal keratinocytes play a vital role in its pathogenesis by acting both as the responder and as the accelerator to the cutaneous psoriatic immune response. Advanced glycation end products (AGEs) are a class of proinflammatory metabolites...

Bibliografski detalji
Glavni autori:	Pan Kang, Jianru Chen, Shiyu Wang, Shaolong Zhang, Shuli Li, Sen Guo, Pu Song, Ling Liu, Gang Wang, Tianwen Gao, Weigang Zhang, Chunying Li
Format:	Članak
Jezik:	English
Izdano:	Karger Publishers 2023-11-01
Serija:	Journal of Innate Immunity
Teme:	advanced glycation end products keratinocyte interleukin-36 alpha signal transducer and activator of transcription 1/3 psoriasis
Online pristup:	https://beta.karger.com/Article/FullText/534639

Slični predmeti

Imbalance of expression levels of IL-36γ and IL-38 is possibly associated with the severity of inflammation in psoriasis vulgaris
od: Jiao ZHANG, i dr.
Izdano: (2023-02-01)

Alloferon and IL-22 receptor expression regulation on the pathogenesis of imiquimod-induced psoriasis
od: Tomoyo Agura, i dr.
Izdano: (2025-02-01)

Imbalance between serum interleukin-36 and interleukin-38 is associated with metabolic syndrome in psoriasis vulgaris
od: Marwa A Amer, i dr.
Izdano: (2023-01-01)

Crosstalk: keratinocytes and immune cells in psoriasis
od: Masahiro Kamata, i dr.
Izdano: (2023-11-01)

Serious generalized pustular psoriasis with evolution to plaque psoriasis: approach with spesolimab
od: Liz S. Gea, i dr.
Izdano: (2024-10-01)

Might Necrotic Keratinocytes Contribute to the Diagnosis and Pathogenesis of Psoriasis?
od: Bengu Cevirgen Cemil, i dr.
Izdano: (2024-07-01)

Advanced Glycation End Products and Psoriasis
od: Martina Maurelli, i dr.
Izdano: (2023-03-01)

The oncogenic kinase TOPK upregulates in psoriatic keratinocytes and contributes to psoriasis progression by regulating neutrophils infiltration
od: Fanfan Zeng, i dr.
Izdano: (2024-08-01)

Tanshinone I Ameliorates Psoriasis-Like Dermatitis by Suppressing Inflammation and Regulating Keratinocyte Differentiation
od: Wang Q, i dr.
Izdano: (2025-01-01)

Knowledge Mapping and Research Hotspots of Generalized Pustular Psoriasis: A Bibliometric Analysis from 2003 to 2023
od: Wei L, i dr.
Izdano: (2023-12-01)

CYP2S1 might regulate proliferation and immune response of keratinocyte in psoriasis
od: Yujun Sheng, i dr.
Izdano: (2021-06-01)

miR-128-3p inhibits the proliferation of keratinocytes in psoriasis via repressing leptin
od: PENG Jing, i dr.
Izdano: (2024-10-01)

LncRNA lnc-SPRR2G-2 contributes to keratinocyte hyperproliferation and inflammation in psoriasis by activating the STAT3 pathway and downregulating KHSRP
od: Yunyue Zhen, i dr.
Izdano: (2024-08-01)

LncRNA NORAD engages in psoriasis by binding to miR-26a to regulate keratinocyte proliferation
od: Shuiqi Li, i dr.
Izdano: (2021-04-01)

Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study
od: Yoshiki Okada, i dr.
Izdano: (2025-02-01)

Benzoylaconitine Alleviates Progression of Psoriasis via Suppressing STAT3 Phosphorylation in Keratinocytes
od: Yuanbo Li, i dr.
Izdano: (2023-05-01)

IL-17A-driven psoriasis is critically dependent on IL-36 signaling
od: Berenice Fischer, i dr.
Izdano: (2023-12-01)

Downregulation of semaphorin 4A in keratinocytes reflects the features of non-lesional psoriasis
od: Miki Kume, i dr.
Izdano: (2024-12-01)

THE GROUNDS OF CLARITROMYCIN USE IN THE TREATMENT OF PSORIASIS
od: V. L. Rybkina
Izdano: (2014-07-01)

Exploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast]
od: Song EJ, i dr.
Izdano: (2023-10-01)

Research Progress on Glycolysis Mechanism of Psoriasis
od: Wei L, i dr.
Izdano: (2024-12-01)

Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments
od: Zhao F, i dr.
Izdano: (2024-05-01)

The role of leptin in psoriasis
od: Lin CHEN, i dr.
Izdano: (2024-03-01)

The Effect of Herbal Medicinal Products on Psoriasis-Like Keratinocytes
od: Fabian Gendrisch, i dr.
Izdano: (2021-03-01)

Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes
od: Ivanka K. Koycheva, i dr.
Izdano: (2021-11-01)

<i>Centipeda minima</i> Extract Inhibits Inflammation and Cell Proliferation by Regulating JAK/STAT Signaling in Macrophages and Keratinocytes
od: Yuanqiang Ma, i dr.
Izdano: (2023-02-01)

Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial
od: Tsen-Fang Tsai, i dr.
Izdano: (2023-10-01)

Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast]
od: Merola JF, i dr.
Izdano: (2024-03-01)

Exploring the Clinical Features, Immunopathogenesis and Approach to Diagnosis for Generalized Pustular Psoriasis [Podcast]
od: Bhutani T, i dr.
Izdano: (2023-06-01)

BCL11B Is Involved in Stress-Induced Differentiation of Keratinocytes and Has A Potential Role in Psoriasis Pathogenesis
od: Sara Parsa, i dr.
Izdano: (2023-05-01)

Unraveling Transcriptome Profile, Epigenetic Dynamics, and Morphological Changes in Psoriasis-like Keratinocytes: “Insights into Similarity with Psoriatic Lesional Epidermis”
od: Ameneh Ghaffarinia, i dr.
Izdano: (2023-12-01)

Interleukin-36 family as a novel regulator of inflammation in the barrier tissues
od: S. V. Sennikova, i dr.
Izdano: (2020-01-01)

Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review
od: Wu M, i dr.
Izdano: (2023-09-01)

The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
od: Jason E. Hawkes, i dr.
Izdano: (2023-11-01)

Implications of LncRNAs and CircRNAs in psoriasis: a review
od: Rongcan Shi, i dr.
Izdano: (2023-12-01)

Leptin induces altered differentiation of keratinocytes by inducing insulin resistance: implications for metabolic syndrome-induced resistance of psoriatic therapy
od: Rui Wang, i dr.
Izdano: (2024-12-01)

Cordycepin inhibits proliferation of human keratinocyte cell line HaCaT induced by TNF-α
od: LIANG Huiyong, WEI Qiuhui, DING Ya, PENG Xiaoqing, YAO Jing, SU Qijian
Izdano: (2023-09-01)

SPRR1B is Related to the Immune Microenvironment and Can Be Used as a Biomarker for the Diagnosis of Psoriasis
od: Hao S, i dr.
Izdano: (2024-02-01)

Critical role of keratinocytes in cutaneous immune responses
od: Rakesh Kumar Gupta, i dr.
Izdano: (2024-08-01)

Studying of the interleukin-36γ expression level in the skin of patients with plaque psoriasis
od: A. Yu. Pashkin, i dr.
Izdano: (2019-10-01)